Want to see FR:BVI full AI Analyst Report?
BVI Stock Chart & Stats
€29.29
€0.18(0.63%)
At close: 4:00 PM EST
€29.29
€0.18(0.63%)
Day’s Range― - ―
52-Week Range€24.58 - €29.76
Previous CloseN/A
Volume60.97K
Average Volume (3M)1.08M
Market Cap
€11.88B
Enterprise Value€13.30B
Total Cash (Recent Filing)€1.37B
Total Debt (Recent Filing)€3.09B
Price to Earnings (P/E)20.3
Beta0.91
Next Earnings
Jul 29, 2026EPS Estimate
0.64Next Dividend Ex-DateN/A
Dividend Yield3.32%
Share Statistics
EPS (TTM)1.32
Shares Outstanding453,871,520
10 Day Avg. Volume713,778
30 Day Avg. Volume1,078,337
Financial Highlights & Ratios
PEG Ratio4.32
Price to Book (P/B)7.08
Price to Sales (P/S)1.87
P/FCF Ratio14.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€30.78Price Target Upside5.08% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
EPS Forecast (FY)1.54
Revenue Forecast (FY)€6.76B
Bulls Say, Bears Say
Bulls Say
Recurring, Regulatory-driven RevenueBureau Veritas' core services are mission-critical, compliance-driven and often contractually recurring. That yields predictable baseline revenue, strong client stickiness and resilient demand through cycles, supporting multi-month visibility into volumes and pricing leverage.
Strong Cash GenerationConsistently high free cash flow provides durable internal funding for capex, dividends and strategic investments. Over time this cash generation enhances flexibility to sustain operations, invest in labs/tech and service debt without immediate reliance on external financing.
Durable Profitability And Steady Revenue GrowthStable mid-single-digit revenue growth combined with healthy operating margins indicates a structurally profitable service model. Persistent margins reflect pricing power, scalable lab/inspection operations and the ability to convert revenues into sustainable operating profits.
Bears Say
Rising Leverage And Weaker Equity BaseElevated and increasing leverage reduces financial flexibility and raises vulnerability to interest-rate or demand shocks. A smaller equity base magnifies solvency risk, limits room for M&A or buybacks, and heightens priority pressure on cash flow allocation toward debt service.
Gross-margin InconsistencyInconsistent gross margins suggest changing mix, cost pressures or classification shifts that obscure true operating leverage. That makes forecasting profitability and assessing sustainable margin targets harder, reducing confidence in long-term margin assumptions.
Cash-conversion / Working-capital DragA sub-0.5 coverage ratio implies operating profit converts to cash more slowly, likely from working-capital timing or collections. Persisting conversion drag can strain liquidity, slow deleveraging, and amplify stress under slower revenue, despite strong headline free cash flow.
Bureau Veritas News
BVI FAQ
What was Bureau Veritas’s price range in the past 12 months?
Bureau Veritas lowest stock price was €24.58 and its highest was €29.76 in the past 12 months.
What is Bureau Veritas’s market cap?
Bureau Veritas’s market cap is €11.88B.
When is Bureau Veritas’s upcoming earnings report date?
Bureau Veritas’s upcoming earnings report date is Jul 29, 2026 which is in 28 days.
How were Bureau Veritas’s earnings last quarter?
Bureau Veritas released its earnings results on Feb 25, 2026. The company reported €0.804 earnings per share for the quarter, the consensus estimate of €0.804 by €0.
Is Bureau Veritas overvalued?
According to Wall Street analysts Bureau Veritas’s price is currently Undervalued.
Does Bureau Veritas pay dividends?
Bureau Veritas pays a Annually dividend of €0.92 which represents an annual dividend yield of 3.32%. See more information on Bureau Veritas dividends here
What is Bureau Veritas’s EPS estimate?
Bureau Veritas’s EPS estimate is 0.64.
How many shares outstanding does Bureau Veritas have?
Bureau Veritas has 453,871,520 shares outstanding.
What happened to Bureau Veritas’s price movement after its last earnings report?
Bureau Veritas reported an EPS of €0.804 in its last earnings report, expectations of €0.804. Following the earnings report the stock price went up 3.99%.
Which hedge fund is a major shareholder of Bureau Veritas?
Currently, no hedge funds are holding shares in FR:BVI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bureau Veritas
Bureau Veritas S.A., a French company, delivers a broad spectrum of global testing, inspection, and certification (TIC) services. Its core mission is to guarantee that products, assets, and management systems meet either mandatory regulations or voluntary industry benchmarks. This is achieved through detailed inspection, analytical assessments, auditing, and certification processes, leading to comprehensive compliance reports. The company offers specialized laboratory and on-site testing for manufacturing and processing industries, alongside inspection services aimed at confirming product quality, quantity, and adherence to regulatory requirements. Additionally, it provides certifications for management systems, specific products, and even individuals. The firm's activities are organized into six distinct divisions: Marine & Offshore; Agri-Food & Commodities; Industry; Buildings & Infrastructure; Certification; and Consumer Products. Bureau Veritas caters to an exceptionally diverse clientele, spanning numerous sectors including automotive, transportation, construction, chemicals, agriculture, consumer products, food, marine, offshore, oil and gas, power, utilities, financial services, and governmental organizations. Established in 1828 and headquartered in Neuilly-sur-Seine, France, the company boasts an extensive international presence, operating approximately 1,600 offices and laboratories across about 140 countries.
BVI Stock 12 Month Forecast
Average Price Target
€30.78
▲(5.08% Upside)
Technical Analysis
bioMerieux
―
Eurofins Scientific
―
ID LOGISTICS
―
Sartorius Stedim Biotech
―
SPIE SA
―
Options Prices
Currently, No data available
---







